Nektar Therapeutics (NKTR) Misses Q1 EPS by 182c
Tweet
Share
E-mail
Get Alerts NKTR Hot Sheet
Price: $68.36 +1.45%
Revenue Growth %: -11.4%
Financial Fact:
Interest expense: -5.61M
Today's EPS Names:
ALZN, ASPU, USAU, More
Revenue Growth %: -11.4%
Financial Fact:
Interest expense: -5.61M
Today's EPS Names:
ALZN, ASPU, USAU, More
Join SI Premium – FREE
Nektar Therapeutics (NASDAQ: NKTR) reported Q1 EPS of ($1.82). Revenue for the quarter came in at $10.9 million.
For earnings history and earnings-related data on Nektar Therapeutics (NKTR) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Nucor projects Q3 2026 earnings above prior year, below estimates
- McDonald's (MCD) Raises Quarterly Dividend 3.8% to $1.93; 3.1% Yield
- JLL (JLL) files mixed shelf
Create E-mail Alert Related Categories
EarningsRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
